CNMDNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
CONMED Corp
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 29, 2026
$46.05−0.67 (-1.43%)
Close on Oct 19, 2026
- Market cap
- $1.39B
- P/E (TTM)
- 24.9
- Dividend yield
- 1.30%
Conmed statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Electromedical & Electrotherapeutic Apparatus companies for comparison
Valuation
| Measure | Conmed | Industry median |
|---|---|---|
| Market Cap | $1.38B | $230.55M |
| Enterprise Value | $2.18B | $202.97M |
| PE Ratio | 24.89 | 31.60 |
| PS Ratio | 1.01 | 3.10 |
| PB Ratio | 1.32 | 3.04 |
| P/FCF Ratio | 10.26 | 27.30 |
| P/OCF Ratio | 9.16 | 22.47 |
Enterprise value
| Measure | Conmed | Industry median |
|---|---|---|
| EV / Sales | 1.59 | 2.91 |
| EV / EBITDA | 19.73 | 19.74 |
| EV / EBIT | 19.73 | 24.80 |
| EV / FCF | 16.18 | 27.89 |
Income (trailing twelve months)
| Measure | Conmed | Industry median |
|---|---|---|
| Revenue | $1.37B | $102.39M |
| Gross Profit | $765.31M | $60.36M |
| Operating Income | $110.32M | -$4.31M |
| Pretax Income | $83.23M | -$2.37M |
| Net Income | $56.50M | -$6.57M |
| EBITDA | $110.32M | -$1.98M |
| EPS (Diluted) | $1.85 | -$0.08 |
Margins
| Measure | Conmed | Industry median |
|---|---|---|
| Gross Margin | 55.8% | 55.2% |
| Operating Margin | 8.04% | -6.04% |
| Pretax Margin | 6.07% | -4.11% |
| Profit Margin | 4.12% | -10.5% |
| EBITDA Margin | 8.04% | -2.67% |
| FCF Margin | 9.80% | 0.02% |
Returns
| Measure | Conmed | Industry median |
|---|---|---|
| Return on Equity (ROE) | 5.53% | -18.2% |
| Return on Assets (ROA) | 2.44% | -13.3% |
| Return on Invested Capital (ROIC) | 4.06% | -3.69% |
| Return on Capital Employed (ROCE) | 5.98% | -9.07% |
Growth
| Measure | Conmed | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 3.42% | 8.85% |
| Net Income Growth (YoY) | -48.7% | 10.5% |
| EPS Growth (YoY) | -47.6% | 10.6% |
| FCF Growth (YoY) | -9.29% | 9.68% |
| Revenue Growth (3Y CAGR) | 9.56% | 7.08% |
| Revenue Growth (5Y CAGR) | 9.77% | 11.8% |
| EPS Growth (5Y CAGR) | 36.4% | 7.64% |
Balance sheet
| Measure | Conmed | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $37.33M | $36.66M |
| Total Debt | $834.25M | $97.65M |
| Net Cash (Debt) | -$796.92M | $3.92M |
| Net Cash Per Share | -$26.61 | $0.28 |
| Equity (Book Value) | $1.04B | $55.33M |
| Book Value Per Share | $34.77 | $2.87 |
| Tangible Book Value | -$319.93M | $10.79M |
| Working Capital | $220.27M | $56.72M |
Financial position
| Measure | Conmed | Industry median |
|---|---|---|
| Current Ratio | 1.48 | 2.48 |
| Quick Ratio | 0.61 | 1.53 |
| Debt / Equity | 0.80 | 0.41 |
| Debt / EBITDA | 7.56 | 2.40 |
| Debt / FCF | 6.20 | 3.49 |
| Net Debt / EBITDA | 7.22 | 1.53 |
| Interest Coverage | 3.69 | -1.85 |
Cash flow (trailing twelve months)
| Measure | Conmed | Industry median |
|---|---|---|
| Operating Cash Flow | $150.59M | -$566.22K |
| Capital Expenditures | -$16.12M | -$3.69M |
| Free Cash Flow | $134.46M | -$696.00K |
| FCF Per Share | $4.49 | -$0.02 |
Efficiency
| Measure | Conmed | Industry median |
|---|---|---|
| Asset Turnover | 0.59 | 0.58 |
| Inventory Turnover | 1.68 | 2.21 |
| Revenue Per Employee | $351.71K | $322.92K |
| Profits Per Employee | $14.49K | -$51.88K |
| Employee Count | 3,900 | 185 |
Dividends and yields
| Measure | Conmed | Industry median |
|---|---|---|
| Earnings Yield | 4.10% | -6.88% |
| FCF Yield | 9.75% | -0.45% |
| Dividend Yield | 1.30% | 0.81% |
| Shareholder Yield | 1.30% | 0.80% |
| Dividend Per Share | $0.60 | $0.72 |
| Dividend Growth (YoY) | -25.0% | 4.80% |
| Years of Dividend Growth | 0 | 0 |
| Payout Ratio | 21.9% | 29.9% |
| FCF Payout Ratio | 9.21% | 21.9% |
Shares
| Measure | Conmed | Industry median |
|---|---|---|
| Shares Outstanding | 29,951,200 | 44,302,700 |
| Shares Change (YoY) | -1.22% | 3.36% |
| Float | 29,721,000 | 37,462,700 |
| Shares Held by Insiders | 0.77% | 10.5% |
| Shares Held by Institutions | 113.8% | 63.5% |
Taxes
| Measure | Conmed | Industry median |
|---|---|---|
| Income Tax | $26.73M | $1.52M |
| Effective Tax Rate | 32.1% | 18.5% |
Scores
| Measure | Conmed | Industry median |
|---|---|---|
| Graham Number | $38.04 | $35.97 |
| Graham Upside | -17.4% | -57.0% |
| Altman Z-Score | 1.91 | 1.95 |
| Piotroski F-Score | 6 | 5 |
Calculated by StockData from Conmed's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.